Atlas Trials

Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

Clinical trial NCT05610319 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05610319
Sponsor
McMaster University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetic Macular Edema
Start date
2023-05-01
Primary completion
2026-12-01
Enrollment
446

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.